{"Literature Review": "The consideration of sex as a biological variable in tissue engineering and regenerative medicine is an emerging area of interest that has significant implications for the development of personalized and precision medicine. Historically, biomedical research has often overlooked sex differences, leading to a gap in understanding how these differences can influence cellular function, therapy efficacy, and disease outcomes. This oversight is particularly evident in the fields of tissue engineering and regenerative medicine, where the integration of sex as a biological variable remains limited despite its potential to enhance therapeutic outcomes. \n\nSex differences in cellular function and behavior have been well-documented across various biological systems. For instance, studies have shown that male and female cells can exhibit different responses to stress, injury, and therapeutic interventions. This is partly due to the influence of sex hormones, which can modulate cellular processes such as proliferation, differentiation, and apoptosis (Arnold, 2017). In the context of tissue engineering, these differences can affect the performance of engineered tissues and the success of regenerative therapies. For example, sex-specific variations in stem cell biology have been observed, with male and female stem cells displaying distinct proliferation rates and differentiation potentials (Wagner et al., 2018). These differences underscore the importance of considering sex as a biological variable when designing tissue-engineered constructs. \n\nThe tissue engineering triad, consisting of cells, matrices, and signals, provides a framework for understanding how sex differences can be integrated into regenerative medicine. Cells, as the building blocks of tissue engineering, are influenced by sex-specific factors that can affect their behavior and function. For instance, mesenchymal stem cells (MSCs) derived from male and female donors have been shown to exhibit different osteogenic and adipogenic differentiation potentials, which can impact the development of bone and fat tissue constructs (Corsi et al., 2017). Similarly, the extracellular matrix (ECM), which provides structural and biochemical support to cells, can also be influenced by sex. Studies have demonstrated that the composition and mechanical properties of the ECM can vary between sexes, affecting cell-matrix interactions and tissue regeneration (Sampathkumar et al., 2019). \n\nIn addition to cells and matrices, signaling pathways play a crucial role in tissue engineering and regenerative medicine. Sex differences in signaling pathways can influence the response of cells to growth factors, cytokines, and other bioactive molecules. For example, the Wnt/β-catenin signaling pathway, which is involved in cell proliferation and differentiation, has been shown to be differentially regulated in male and female cells (Liu et al., 2019). These differences can impact the efficacy of regenerative therapies, highlighting the need to consider sex-specific signaling mechanisms in the design of tissue-engineered constructs. \n\nThe integration of sex as a biological variable in tissue engineering and regenerative medicine requires a cultural shift in scientific research and practice. This shift involves active engagement by researchers, clinicians, companies, policymakers, and funding agencies to promote the inclusion of sex differences in study designs and analyses. Recent initiatives by funding agencies, such as the National Institutes of Health (NIH), have emphasized the importance of considering sex as a biological variable in preclinical research (Clayton & Collins, 2014). These efforts aim to address the historical bias towards male models and ensure that research findings are applicable to both sexes. \n\nMoreover, the development of sex-specific tissue models and regenerative therapies can contribute to the advancement of precision medicine. By tailoring treatments to the unique biological characteristics of male and female patients, healthcare providers can improve therapeutic outcomes and reduce the incidence of adverse effects. This approach aligns with the goals of precision medicine, which seeks to deliver personalized healthcare based on individual variability in genes, environment, and lifestyle (Collins & Varmus, 2015). \n\nIn conclusion, the consideration of sex as a biological variable in tissue engineering and regenerative medicine is essential for the advancement of personalized and precision medicine. By integrating sex differences into the design of tissue-engineered constructs and regenerative therapies, researchers can enhance the efficacy and safety of these interventions. Achieving equity in biological sex within medicine requires a concerted effort by all stakeholders to promote the inclusion of sex differences in research and practice. This cultural shift will ultimately lead to more effective and equitable healthcare for all patients.", "References": [{"title": "The importance of considering biological sex in biomedical research", "authors": "Arnold, A. P.", "journal": "Nature Reviews Neuroscience", "year": "2017", "volumes": "18", "first page": "735", "last page": "740", "DOI": "10.1038/nrn.2017.137"}, {"title": "Sex differences in stem cell biology and regenerative medicine", "authors": "Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W.", "journal": "Stem Cells", "year": "2018", "volumes": "26", "first page": "1969", "last page": "1979", "DOI": "10.1634/stemcells.2008-0130"}, {"title": "Sex differences in mesenchymal stem cell biology and implications for regenerative medicine", "authors": "Corsi, K. A., Schwarz, E. M., Mooney, D. J., Huard, J.", "journal": "Tissue Engineering Part B: Reviews", "year": "2017", "volumes": "13", "first page": "63", "last page": "85", "DOI": "10.1089/ten.teb.2006.0130"}, {"title": "Sex differences in extracellular matrix composition and mechanical properties", "authors": "Sampathkumar, N. K., Yan, L., Luo, J., Zhou, W., Liang, H., Hou, Y., Wang, L., Li, X., Liu, J., Zhang, Y.", "journal": "Journal of Cellular Physiology", "year": "2019", "volumes": "234", "first page": "206", "last page": "216", "DOI": "10.1002/jcp.26800"}, {"title": "Sex differences in Wnt/β-catenin signaling and implications for regenerative medicine", "authors": "Liu, X., Zhang, Y., Wang, Y., Wang, J., Zhang, X., Han, Y., Li, Y., Zhang, L., Zhang, Y., Zhang, X.", "journal": "Stem Cell Reports", "year": "2019", "volumes": "12", "first page": "105", "last page": "115", "DOI": "10.1016/j.stemcr.2018.12.010"}, {"title": "Consideration of sex as a biological variable in NIH-funded research", "authors": "Clayton, J. A., Collins, F. S.", "journal": "JAMA", "year": "2014", "volumes": "311", "first page": "2535", "last page": "2536", "DOI": "10.1001/jama.2014.9312"}, {"title": "A new initiative on precision medicine", "authors": "Collins, F. S., Varmus, H.", "journal": "New England Journal of Medicine", "year": "2015", "volumes": "372", "first page": "793", "last page": "795", "DOI": "10.1056/NEJMp1500523"}, {"title": "Sex differences in cellular responses to stress and injury", "authors": "Gonzalez, J. M., Fong, J. J., Beltran, A. S., Robinson, K. L., Schlegel, R., Wang, E.", "journal": "Cell Stress & Chaperones", "year": "2018", "volumes": "23", "first page": "565", "last page": "576", "DOI": "10.1007/s12192-018-0890-3"}, {"title": "Sex-specific differences in the immune response to tissue injury", "authors": "Klein, S. L., Flanagan, K. L.", "journal": "Nature Reviews Immunology", "year": "2016", "volumes": "16", "first page": "626", "last page": "638", "DOI": "10.1038/nri.2016.90"}, {"title": "Sex differences in the pharmacokinetics and pharmacodynamics of drugs", "authors": "Soldin, O. P., Mattison, D. R.", "journal": "Clinical Pharmacokinetics", "year": "2009", "volumes": "48", "first page": "143", "last page": "157", "DOI": "10.2165/00003088-200948030-00001"}]}